Trump Administration to End Medicare Drug Subsidy Program, Citing Taxpayer Savings

The Trump administration announced it is ending a Medicare drug subsidy program, with CMS Administrator Dr. Mehmet Oz stating the decision would save billions in taxpayer dollars by preventing funds from going to insurance companies. The program reportedly cost the agency an estimated $3.6 billion in 2026. Democrats have criticized the move, arguing it will increase prescription drug costs for 25 million seniors.